1. Sentinel lymph node biopsy and morbidity outcomes in early cervical cancer: Results of a multicentre randomised trial (SENTICOL-2)
- Author
-
Yves Fouche, Marc Baron, Florent Boutitie, G. Houvenaeghel, Daniel Raudrant, Eric Leblanc, Catherine Uzan, V. Fourchotte, J-M Classe, P. Morice, Anne-Sophie Bats, Fabrice Lecuru, C. Pomel, L. Boulanger, Jean Levêque, G. Mage, Olivier Graesslin, Patrice Mathevet, Frederic Guyon, Emile Daraï, Vanessa Conri, Philippe Descamps, Jean-Jacques Baldauf, Henri Marret, A S Bats, Denis Querleu, Virginie Fourchotte, Laurent Magaud, B. Ott, Serge Douvier, E. Stoeckle, P. Rouanet, P. Mathevet, Manuel González Barón, D. Lanvin, and Y. Delpech
- Subjects
Adult ,0301 basic medicine ,Cancer Research ,medicine.medical_specialty ,medicine.medical_treatment ,Sentinel lymph node ,Uterine Cervical Neoplasms ,Adenocarcinoma ,Hysterectomy ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Humans ,Prospective Studies ,Radical surgery ,Radical Hysterectomy ,Lymph node ,Cervical cancer ,Sentinel Lymph Node Biopsy ,business.industry ,Middle Aged ,Sentinel node ,Prognosis ,medicine.disease ,Surgery ,Survival Rate ,Dissection ,030104 developmental biology ,medicine.anatomical_structure ,Oncology ,030220 oncology & carcinogenesis ,Carcinoma, Squamous Cell ,Lymph Node Excision ,Female ,Lymphadenectomy ,Morbidity ,Neoplasm Recurrence, Local ,business ,Follow-Up Studies - Abstract
Introduction Pelvic lymph node dissection has been the standard of care for patients with early cervical cancer. Sentinel node (SN) mapping is safe and feasible and may increase the detection of metastatic disease, but benefits of omitting pelvic lymph node dissection in terms of decreased morbidity have not been demonstrated. Materials and methods In an open-label study, patients with early cervical carcinoma (FIGO 2009 stage IA2 to IIA1) were randomly assigned to SN resection alone (SN arm) or SN and pelvic lymph node dissection (SN + PLND arm). SN resection was followed by radical surgery of the tumour (radical hysterectomy or radical trachelectomy). The primary end-point was morbidity related to the lymph node dissection; 3-year recurrence-free survival was a secondary end-point. Results A total of 206 patients were eligible and randomly assigned to the SN arm (105 patients) or SN + PLND arm (101 patients). Most patients had stage IB1 lesion (87.4%). No false-negative case was observed in SN + PLND arm. Lymphatic morbidity was significantly lower in the SN arm (31.4%) than in the SN + PLND arm (51.5%; p = 0.0046), as was the rate of postoperative neurological symptoms (7.8% vs. 20.6%, p = 0.01, respectively). However, there was no significant difference in the proportion of patients with significant lymphoedema between the two groups. During the 6-month postoperative period, the difference in morbidity decreased over time. The 3-year recurrence-free survival was not significantly different (92.0% in SN arm and 94.4% in SN + PLND arm). Conclusion SN resection alone is associated with early decreased lymphatic morbidity when compared with SN + PLND in early cervical cancer.
- Published
- 2021
- Full Text
- View/download PDF